v3.6.0.2
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Cash flows from operating activities attributable to continuing operations:      
Net (loss) earnings $ (16,151) $ 113,374 $ 409,230
Less: earnings from discontinued operations, net of tax 189 17 174,673
(Loss) earnings from continuing operations (16,340) 113,357 234,557
Adjustments to reconcile (loss) earnings from continuing operations to net cash provided by operating activities attributable to continuing operations:      
Stock-based compensation expense 104,820 105,450 59,634
Depreciation 71,676 62,205 61,156
Amortization of intangibles 79,426 139,952 57,926
Goodwill impairment 275,367 14,056 0
Impairment of long-term investments 10,680 6,689 66,601
Excess tax benefits from stock-based awards (51,764) (56,418) (44,957)
Deferred income taxes (119,181) (59,786) 76,869
Equity in losses (earnings) of unconsolidated affiliates 549 (772) 9,697
Acquisition-related contingent consideration fair value adjustments 2,555 (15,461) (13,367)
Gains on sale of businesses, investments and assets, net (50,965) (1,005) (21,946)
Gain on real estate transaction 0 (34,341) 0
Other adjustments, net 4,734 26,496 20,789
Changes in assets and liabilities, net of effects of acquisitions and dispositions:      
Accounts receivable 1,283 (29,680) (19,918)
Other assets (12,905) (21,174) (3,606)
Accounts payable and other current liabilities (52,359) 8,756 4,963
Income taxes payable 8,998 24,167 (94,492)
Deferred revenue 35,803 66,914 30,142
Net cash provided by operating activities attributable to continuing operations 292,377 349,405 424,048
Cash flows from investing activities attributable to continuing operations:      
Acquisitions, net of cash acquired (18,403) (617,402) (259,391)
Capital expenditures (78,039) (62,049) (57,233)
Investments in time deposits (87,500) 0 0
Proceeds from maturities of time deposits 87,500 0 0
Proceeds from maturities and sales of marketable debt securities 252,369 218,462 21,644
Purchases of marketable debt securities (313,943) (93,134) (175,826)
Purchases of investments (12,565) (34,470) (24,334)
Net proceeds from the sale of businesses, investments and assets 172,228 9,413 58,388
Other, net 11,215 (3,541) (3,042)
Net cash provided by (used in) investing activities attributable to continuing operations 12,862 (582,721) (439,794)
Cash flows from financing activities attributable to continuing operations:      
Borrowings under Match Group Term Loan 0 788,000 0
Principal payments on Match Group Term Loan (450,000) 0 0
Proceeds from Match Group 2016 Senior Notes offering 400,000 0 0
Principal payments on IAC debt, including redemptions and repurchases of Senior Notes (126,409) (80,000) 0
Debt issuance costs (7,811) (19,050) (383)
Fees and expenses related to note exchange 0 (6,954) 0
Proceeds from Match Group initial public offering, net of fees and expenses 0 428,789 0
Purchase of treasury stock (308,948) (200,000) 0
Dividends 0 (113,196) (97,338)
Issuance of IAC common stock pursuant to stock-based awards, net of withholding taxes (895) (38,418) 1,609
Issuance of Match Group common stock pursuant to stock-based awards, net of withholding taxes 9,548 0 0
Repurchase of stock-based awards 0 (23,431) 0
Excess tax benefits from stock-based awards 51,764 56,418 44,957
Purchase of noncontrolling interests (2,740) (32,207) (33,165)
Acquisition-related contingent consideration payments (2,180) (5,750) (8,109)
Funds held in escrow for MyHammer tender offer (10,548) 0 0
Other, net (2,846) (19,393) 11,449
Net cash (used in) provided by financing activities attributable to continuing operations (451,065) 734,808 (80,980)
Total cash (used in) provided by continuing operations (145,826) 501,492 (96,726)
Total cash used in discontinued operations 0 (152) (145)
Effect of exchange rate changes on cash and cash equivalents (6,434) (10,298) (13,168)
Net (decrease) increase in cash and cash equivalents (152,260) 491,042 (110,039)
Cash and cash equivalents at beginning of period 1,481,447 990,405 1,100,444
Cash and cash equivalents at end of period $ 1,329,187 $ 1,481,447 $ 990,405